Dylan J. Edwards, Ph.D., P.T.
Director, Non-Invasive Brain Stimulation and Human Motor Control Laboratory
Burke Medical Research Institute & Weill Cornell Medicine
Hermano Igo Krebs, Ph.D.
Principal Research Scientist and Lecturer – Newman Laboratory for Biomechanics and Human Rehabilitation
Mechanical Engineering Department at Massachusetts Institute of Technology
Bruce T. Volpe, M.D.
Investigator, Laboratory of Biomedical Science, The Feinstein Institute for Medical Research
Professor, Department of Molecular Medicine, Hofstra Northwell School of Medicine
Joel Stein, M.D.
Physiatrist-in-Chief, NewYork-Presbyterian Hospital
Professor and Chair, Department of Rehabilitation Medicine, Columbia University College of Physicians and Surgeons
Professor and Chief, Division of Rehabilitation Medicine, Weill Cornell Medical College
Avrielle Rykman Peltz, MA, OTR/L
Sr. Clinical Administrator - Robotics and Virtual Reality
Co-Founder and Chief Operating Officer of the Restorative Neurology Clinic, Burke Medical Research Institute
Advanced Clinician/Occupational Therapy, Restorative Neurology Clinic, Burke Medical Research Institute
Mar Cortes, M.D.
Clinical Scientist, Non-Invasive Brain Stimulation and Human Motor Control Laboratory, Burke Medical Research Institute
Bionik (formerly Interactive Motion Technologies)
Interactive Motion Technologies, Inc., now known as Bionik, Inc. following a merger with Bionik Laboratories, Inc., is the global pioneer in advanced rehabilitation solutions for patients with upper extremity motor impairments due to neurological injury. Our InMotion Neuro-Recovery Systems are the most thoroughly researched technology in neurorehabilitation and were originally developed and patented by leading scientists and researchers at the Massachusetts Institute of Technology. Our robotic devices are designed to be fully interactive, providing assistance only where needed, and allowing the patient to complete discrete task oriented movements as he/she can on their own. By constantly challenging the patient according to his/her needs, the technology is adaptive and intelligent. Our outcomes have been consistently superior in the scientific literature as well as in clinic settings, for acute, subacute and chronic patients. And while many of the software protocols of InMotion Systems are designed to assist even severely impaired patients, the adaptive nature of our robotic systems allows for improvement with more mildly impaired patients as well.
Our devices provide an easy set-up for ambulatory and wheel-chair bound patients, and offer real-time patient progress reporting, evaluation tools and the full set of therapeutic games and protocols. They can be used with adults and children.
Ekso Bionics is the maker of Ekso™ GT - the first exoskeleton FDA cleared for use with stroke, and spinal cord injury levels to C7. Ekso GT with smart Variable Assist™ software is the only exoskeleton available for rehabilitation institutions that can provide adaptive amounts of power to either side of the patient’s body, challenging the patient as they progress through their continuum of care.
Myomo®, Inc. is a medical technology company leading the way in extending myoelectric prosthetic technology to powered orthoses that restore an individual's mobility. The company's mission is to improve mobility and restore independence for individuals suffering from a paralyzed arm due to Brachial plexus injury, Stroke and other neuro-muscular conditions. The Company manufactures and sells the MyoPro® myoelectric upper extremity orthosis.
The MyoPro is designed to enable individuals to self-initiate and control movement of a partially paralyzed arm using their own muscle signals. Similar to a myoelectric controlled prosthetic, the orthosis uses simple surface EMG sensing technology. When signal is detected, the motor is actuated to move the arm in the desired direction. The user is completely controlling his own arm; the brace assists with movement once a weak signal is detected. With the orthosis, a paralyzed individual can perform activities of daily living including feeding, reaching, and lifting.
The MyoPro technology was invented by researchers at the Massachusetts Institute of Technology and has been in use at clinics as a therapy device since FDA approval in 2007. Since 2010, the technology has been used in the home to assist in improving upper limb function.
Tyromotion GmbH is one of the world-wide leading manufacturers and distributors of robot- and computer-assisted therapy units for the rehabilitation sector. The company focusses on the development of novel technologies based on the use of powerful mechatronic systems for rehabilitation. These systems help physicians and therapists to reach their goal of guiding their patients through the rehabilitation process faster and in a more motivating way. Today the innovative therapy units of Tyromotion GmbH are being used in rehabilitation centers and clinics world-wide. By now, the company with headquarters in Graz has additional branch establishments in Germany and the USA. The distribution network extends across the entire globe.
Hocoma is the global market leader for the development, manufacturing and marketing of robotic and sensorbased devices for functional movement therapy.
We develop all of our innovative therapy solutions in close cooperation with leading clinics and research centers. The product range features devices for intensive gait therapy (Lokomat®, Andago®), functional therapy of the upper extremities (Armeo®), early rehabilitation and patient mobilization (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo®) at home and at the therapist.
Our products are applied successfully in renowned clinics and research institutes worldwide in the field of rehabilitation medicine.